230 related articles for article (PubMed ID: 22420575)
1. Recent advances in computational studies on influenza a virus M2 proton channel.
Wang JF; Chou KC
Mini Rev Med Chem; 2012 Sep; 12(10):971-8. PubMed ID: 22420575
[TBL] [Abstract][Full Text] [Related]
2. Put a cork in it: Plugging the M2 viral ion channel to sink influenza.
Jalily PH; Duncan MC; Fedida D; Wang J; Tietjen I
Antiviral Res; 2020 Jun; 178():104780. PubMed ID: 32229237
[TBL] [Abstract][Full Text] [Related]
3. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
Moorthy NS; Poongavanam V; Pratheepa V
Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
[TBL] [Abstract][Full Text] [Related]
4. Designing inhibitors of M2 proton channel against H1N1 swine influenza virus.
Du QS; Huang RB; Wang SQ; Chou KC
PLoS One; 2010 Feb; 5(2):e9388. PubMed ID: 20186344
[TBL] [Abstract][Full Text] [Related]
5. Structural and energetic analysis of drug inhibition of the influenza A M2 proton channel.
Gu RX; Liu LA; Wei DQ
Trends Pharmacol Sci; 2013 Oct; 34(10):571-80. PubMed ID: 24011996
[TBL] [Abstract][Full Text] [Related]
6. Flu channel drug resistance: a tale of two sites.
Pielak RM; Chou JJ
Protein Cell; 2010 Mar; 1(3):246-58. PubMed ID: 21203971
[TBL] [Abstract][Full Text] [Related]
7. Computational study of drug binding to the membrane-bound tetrameric M2 peptide bundle from influenza A virus.
Khurana E; Devane RH; Dal Peraro M; Klein ML
Biochim Biophys Acta; 2011 Feb; 1808(2):530-7. PubMed ID: 20385097
[TBL] [Abstract][Full Text] [Related]
8. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
[TBL] [Abstract][Full Text] [Related]
9. Expeditious Lead Optimization of Isoxazole-Containing Influenza A Virus M2-S31N Inhibitors Using the Suzuki-Miyaura Cross-Coupling Reaction.
Li F; Hu Y; Wang Y; Ma C; Wang J
J Med Chem; 2017 Feb; 60(4):1580-1590. PubMed ID: 28182419
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel.
Li F; Ma C; Hu Y; Wang Y; Wang J
ACS Infect Dis; 2016 Oct; 2(10):726-733. PubMed ID: 27657178
[TBL] [Abstract][Full Text] [Related]
11. Structural and dynamic mechanisms for the function and inhibition of the M2 proton channel from influenza A virus.
Wang J; Qiu JX; Soto C; DeGrado WF
Curr Opin Struct Biol; 2011 Feb; 21(1):68-80. PubMed ID: 21247754
[TBL] [Abstract][Full Text] [Related]
12. Viroporins in the Influenza Virus.
To J; Torres J
Cells; 2019 Jun; 8(7):. PubMed ID: 31261944
[TBL] [Abstract][Full Text] [Related]
13. Functional studies reveal the similarities and differences between AM2 and BM2 proton channels from influenza viruses.
Ma C; Wang J
Biochim Biophys Acta Biomembr; 2018 Feb; 1860(2):272-280. PubMed ID: 29106970
[TBL] [Abstract][Full Text] [Related]
14. The L46P mutant confers a novel allosteric mechanism of resistance toward the influenza A virus M2 S31N proton channel blockers.
Musharrafieh R; Lagarias PI; Ma C; Tan GS; Kolocouris A; Wang J
Mol Pharmacol; 2019 Aug; 96(2):148-157. PubMed ID: 31175183
[TBL] [Abstract][Full Text] [Related]
15. Viroporins: structure, function and potential as antiviral targets.
Scott C; Griffin S
J Gen Virol; 2015 Aug; 96(8):2000-2027. PubMed ID: 26023149
[TBL] [Abstract][Full Text] [Related]
16. Controlling influenza virus replication by inhibiting its proton channel.
Pinto LH; Lamb RA
Mol Biosyst; 2007 Jan; 3(1):18-23. PubMed ID: 17216051
[TBL] [Abstract][Full Text] [Related]
17. Functional studies and modeling of pore-lining residue mutants of the influenza a virus M2 ion channel.
Balannik V; Carnevale V; Fiorin G; Levine BG; Lamb RA; Klein ML; Degrado WF; Pinto LH
Biochemistry; 2010 Feb; 49(4):696-708. PubMed ID: 20028125
[TBL] [Abstract][Full Text] [Related]
18. Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus.
Balannik V; Wang J; Ohigashi Y; Jing X; Magavern E; Lamb RA; Degrado WF; Pinto LH
Biochemistry; 2009 Dec; 48(50):11872-82. PubMed ID: 19905033
[TBL] [Abstract][Full Text] [Related]
19. Detection of proton movement directly across viral membranes to identify novel influenza virus M2 inhibitors.
Sulli C; Banik SS; Schilling J; Moser A; Xiang X; Payne R; Wanless A; Willis SH; Paes C; Rucker JB; Doranz BJ
J Virol; 2013 Oct; 87(19):10679-86. PubMed ID: 23885079
[TBL] [Abstract][Full Text] [Related]
20. Protein structural defects enable pharmaceutical targeting while functionalizing the M2 proton channel.
Fernández A
Biochem Biophys Res Commun; 2019 Jun; 514(1):86-91. PubMed ID: 31023526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
